Xerostomia Therapeutics Market Growth Drivers, Strategies, Trends, and Forecast by 2031

Name: Market Overview - Xerostomia Therapeutics
Creator: The Insight Partners
License: https://www.theinsightpartners.com/terms-and-conditions

Xerostomia Therapeutics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage:by Product (Salivary Stimulants, Salivary Substitutes, Dentifrices); Type (OTC, Prescription), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031

Report Date : Apr 2026
Report Code : TIPRE00004316

Category : Life Sciences
Status : Upcoming

Available Report Formats :
No. of Pages : 150

Also Available in :

Korean German Japanese French Chinese Italian Spanish

Buy Now

Xerostomia Therapeutics Market Growth Drivers, Strategies, Trends, and Forecast by 2031

Report Date: Apr 2026 | Report Code: TIPRE00004316

Buy Now

Page Updated: Jan 2025

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The Xerostomia Therapeutics Market size is expected to reach US$ 2.36 Billion by 2031. The market is anticipated to register a CAGR of 5.8% during 2025-2031.

The Xerostomia Therapeutics Market report covers analysis by Product (Salivary Stimulants, Salivary Substitutes, Dentifrices); Type (OTC, Prescription), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Xerostomia Therapeutics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Xerostomia Therapeutics Market Segmentation Product

Salivary Stimulants
Salivary Substitutes
Dentifrices

Type

OTC
Prescription

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Xerostomia Therapeutics Market: Strategic Insights

Get Top Key Market Trends of this report.
This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Xerostomia Therapeutics Market Growth Drivers

Rising Prevalence of Xerostomia:
The growing incidence of xerostomia, especially among the aging population and cancer patients undergoing treatments like radiation, is driving the demand for effective therapeutics.
Side Effects of Cancer Treatments:
Chemotherapy and head and neck radiation therapies often lead to dry mouth as a side effect, significantly increasing the need for xerostomia treatment options.

Aging Population:
As the global elderly population increases, the prevalence of conditions leading to xerostomia, such as Sj

Xerostomia Therapeutics Market Regional Insights

The regional trends and factors influencing the Xerostomia Therapeutics Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Xerostomia Therapeutics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Xerostomia Therapeutics Market Report Scope

By Type

OTC
Prescription

Europe

UK
Germany
France
Russia
Italy
Rest of Europe

Asia-Pacific

China
India
Japan
Australia
Rest of Asia-Pacific

South and Central America

Brazil
Argentina
Rest of South and Central America

Middle East and Africa

South Africa
Saudi Arabia
UAE
Rest of Middle East and Africa

Report Attribute	Details
Market size in 2024	US$ XX Billion
Market Size by 2031	US$ 2.36 Billion
Global CAGR (2025 - 2031)	5.8%
Historical Data	2021-2023
Forecast period	2025-2031
Segments Covered	By Product Salivary Stimulants Salivary Substitutes Dentifrices
Regions and Countries Covered	North America US Canada Mexico
Market leaders and key company profiles	Acacia Pharma Pfizer, Inc. GlaxoSmithKline plc Church & Dwight Co., Inc. Lupin Sun Pharmaceutical Industries, Ltd. Hikma Pharmaceuticals PLC Pendopharm OraCoat Parnell Pharmaceuticals, Inc.

Xerostomia Therapeutics Market Players Density: Understanding Its Impact on Business Dynamics

The Xerostomia Therapeutics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Frequently Asked Questions

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Key companies of this market are: Acacia Pharma, Pfizer, Inc., GlaxoSmithKline plc, Church & Dwight Co., Inc., Lupin, Sun Pharmaceutical Industries, Ltd., Hikma Pharmaceuticals PLC, Pendopharm, OraCoat, Parnell Pharmaceuticals, Inc.

Key future trends in this market are - Expanding Patient Awareness, Natural and Organic Products, Geriatric Population

The Xerostomia Therapeutics Market is estimated to witness a CAGR of 5.8% from 2025 to 2031.

The major factors driving the market are: Growing geriatric population, Rising awareness of oral health, Advancements in treatment options

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Xerostomia Therapeutics Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

RAN KEDEM Partner, Reali Technologies LTDs

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

JEAN-HERVE JENN Chairman, Future Analytica

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

Reason to Buy